期刊文献+

血清胱抑素C、糖化血红蛋白及血液流变学与2型糖尿病肾病的关系 被引量:34

下载PDF
导出
摘要 目的探讨血清胱抑素C(CysC)、糖化血红蛋白(HbA1C)及血液流变学与2型糖尿病肾病病程的关系。方法根据尿白蛋白排泄率将104例2型糖尿病患者分为糖尿病非肾病组(48例)和糖尿病肾病组(56例),并选择健康者30例作为对照组,进行血清CysC、HbA1C及血液流变学各项指标检测。结果糖尿病肾病组HbA1C、CysC、血液流变学各项指标显著高于糖尿病非肾病组及对照组(P<0.01)。糖尿病肾病组病程明显长于糖尿病非肾病组(P<0.01)。Pearson相关分析显示,HbA1C与CysC、血肌酐、血清β2微球蛋白(β2-MG)、病程均呈正相关(P<0.01),CysC与血β2-MG、病程呈正相关(P<0.05),CysC、HbA1C与血液流变指标中的红细胞聚集指数、全血黏度(低切)、全血黏度(中切)、全血黏度(高切)、全血还原黏度(低切)、全血还原黏度(中切)、全血还原黏度(高切)均呈正相关(P<0.01)。结论糖尿病肾病与病程、持续高血糖、血液流变血异常有关,长期控制血糖、改善血液流变性,对预防和治疗糖尿病肾病变有非常重要的意义。
出处 《广东医学》 CAS CSCD 北大核心 2012年第4期496-498,共3页 Guangdong Medical Journal
  • 相关文献

参考文献8

  • 1NEGREAN V,SUCIU I,SAMPELEAN D,et al.Rheological changes in diabetic microangiopathy[J].Rom J Intern Med,2004,42(2):407-413.
  • 2LE DEVEHAT C,VIMEUX M,KHODABANDEHLOU T.Blood theology in patients with diabetes mellitus[J].Clin Hemorheol Microcirc,2004,30(3/4):297-300.
  • 3YLINEN E A,ALA HOUHALA M,HARMOINEN A P,et al.Cystatin C as a marker for glomerular filtration rate in pediatric patients[J].Pedia Nephrol,1999,13(6):506-509.
  • 4李玉艳,杨振坤,李强.胱抑素C在临床中的应用进展[J].国际检验医学杂志,2006,27(9):812-813. 被引量:106
  • 5COIL E,BOTEY A,ALVAREZ L,et al.Serum cystatin C as a newmarker for noninvasive eatimation of glomerular tiltration rate and as a marker for erarly impairment[J].Am J Kidney Dis,2000,36(1):29-34.
  • 6李仙丽,冯显红,姚爱军,徐建良.血清胱抑素C与β_2微球蛋白在糖尿病肾病早期诊断中的价值[J].检验医学与临床,2011,8(7):784-785. 被引量:19
  • 7KHAW K T,WAREHAM N,BINGHAM S,et al.Association of hemoglobin Alc with cardiovascular disease and mortality in adults:the european prospective investigation into cancer in norfolk[J].Ann Intern Med,2004,141(6):413-420.
  • 8LAMARCHE B,TCHERNOF A,MOORJANI S,et al.Small dense low-density lipoprotein particles as a predictor of the risk of isehemie heart disease in men:prospective results from the Québec Cardiovascular Study[J].Circulation,1997,95(1):69-75.

二级参考文献22

  • 1苏彩女 何洁明 胡开如.血、尿微量蛋白测定对糖尿病肾病早期诊断价值的探讨.放射免疫学杂,:502-504.
  • 2Keevil BG,Kilpit ruk ES,Nichols SP,et al.Biological variationof cystatin C:impluations for the assesment of glo-merularfih ration rate[J].Clin Chem,1998,44(7):1535-1539.
  • 3Coll E,Botey A,Alvarez L,et al.Serum cystatin C as a newmarker for noninvasive eatimation of glomerular titrationrate and as a marker for erarly impairment[J].AmJ Kidney Dis,2000,36(1):29-34.
  • 4陈灏珠.实用内科学[M]12版.北京:人民卫生出版社,2005.1746-1750.
  • 5Zore I, Krasovec M, Cimerman N, et al. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem, 2001, 382(5): 805-810.
  • 6Takeuchi M, Fukuda Y, Nakano I, et al. Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur J Gastroenterol Hepatol, 2001, 13(8): 951-955.
  • 7Domej W, Tilz GP, Foldes-Papp Z, et al. Cystatin C of pleural effusion as a novel diagnostic aid in pleural diseases of different aetiologies. Clin Sci (Lond), 2002, 102 (3) :373-380.
  • 8Mannes AJ, Martin BM, Yang HY, et al. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain,2003, 102(3): 251-256.
  • 9Eisenach JC, Thomas JA, Rauck RL, et al. Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans. Pain, 2004, 107(3): 207-212.
  • 10Gupta-Malhotra M, Levine DM, Cooper RS, et al. Decreased levels of cystatin C, an inhibitor of the elastolytic enzyme cysteine protease, in acute and subacute phases of kawasaki disease. Cardiology, 2003, 99(3): 121-125.

共引文献123

同被引文献347

引证文献34

二级引证文献212

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部